Sarah Glass | Chief Operating Officer
n-Lorem Foundation

Sarah Glass, PhD, is Chief Operating Officer at the n-Lorem Foundation, where she leads global operations to bring individualized RNA-based medicines to patients with nano-rare diseases—those affecting only a single individual worldwide. Trained as a geneticist and driven by her personal experience as a parent of a child with a nano-rare condition, Dr. Glass has spent her career bridging science, compassion, and operational excellence. Prior to n-Lorem, she led rare disease and genomic medicine programs at Parexel, Teva Pharmaceuticals, and GlaxoSmithKline. Her work focuses on building sustainable, scalable solutions that deliver life-changing therapies to those who previously had no options.